Absorbable stent for recurrent tear duct infection
Part of Ear, nose & throat, Eyes & vision clinical trials.
This trial tests a new type of dissolvable stent that slowly releases medicine to treat chronic tear duct infections that have come back after previous surgery. It may help people who need another treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with long-term tear duct infection (chronic dacryocystitis).
- You have had a prior surgery for this infection that did not work or the problem returned.
- An imaging test shows your tear duct sac is at least 4 millimeters wide.
- You are 18 years old or older.
- You can understand and agree to the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new light-activated gel to help keep the tear duct open after standard surgery. It may reduce the chance of the duct closing again.
This trial compares different ways to manage the flap during external dacryocystorhinostomy (a surgery to clear blocked tear ducts). It may help if you have a blocked tear duct, a tear sac infection or a tear sac cyst or fistula.
This study tests if adding a medicine called 5-FU to standard tear duct surgery helps people with a small tear drainage sac get better results. It might be an option if you have a blocked tear duct and a very small sac.
This study compares two medications (hyaluronic acid and mitomycin-C) used during a surgery to open a blocked tear duct. It aims to see which one helps the new tear channel stay open longer, especially for people with chronic eye discharge or tearing.
This trial tests whether using four balloon inflation points during tear duct surgery works better than the standard two points for people with blocked tear ducts. It aims to improve tear drainage and reduce symptoms.
This study tests a new sinus stent that slowly releases medicine to treat chronic sinusitis in both nostrils. The goal is to see if it helps reduce symptoms and inflammation better than usual care.
Hear when a new Chronic Dacryocystitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.